<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="EN" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Neurol Sci</journal-id>
      <journal-title>Neurological Sciences</journal-title>
      <issn pub-type="ppub">1590-1874</issn>
      <issn pub-type="epub">1590-3478</issn>
      <publisher>
        <publisher-name>Springer Milan</publisher-name>
        <publisher-loc>Milan</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">19444382</article-id>
      <article-id pub-id-type="pmc">2707857</article-id>
      <article-id pub-id-type="publisher-id">88</article-id>
      <article-id pub-id-type="doi">10.1007/s10072-009-0088-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Transient parkinsonism in isolated extrapontine myelinolysis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Post</surname>
            <given-names>Bart</given-names>
          </name>
          <address>
            <email>b.post@amc.uva.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>van Gool</surname>
            <given-names>W. A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Tijssen</surname>
            <given-names>M. A. J.</given-names>
          </name>
          <address>
            <phone>+31-20-5663842</phone>
            <fax>+31-20-6971438</fax>
            <email>m.a.tijssen@amc.uva.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Neurology and Clinical Neurophysiology, Academic Medical Center, Amsterdam, The Netherlands </aff>
        <aff id="Aff2"><label>2</label>Department of Neurology H2-222, Academic Medical Center, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>5</month>
        <year>2009</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2009</year>
      </pub-date>
      <volume>30</volume>
      <issue>4</issue>
      <fpage>325</fpage>
      <lpage>328</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>4</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>4</month>
          <year>2009</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2009</copyright-statement>
      </permissions>
      <abstract xml:lang="EN">
        <p>Extrapontine myelinolysis (EPM) is a rare cause of parkinsonism. In this case report, we describe a 63-year-old woman with parkinsonism due to EPM after correction of hyponatremia. During a 4-year follow-up, both the clinical features of parkinsonism and the changes on magnetic resonance imaging resolved. Parkinsonism due to EPM should be recognized as it has a good prognosis.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Parkinsonism</kwd>
        <kwd>Extrapontine myelinolysis</kwd>
        <kwd>Hyponatremia</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2009</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Parkinsonism is mostly due to Parkinson&#x2019;s disease, vascular parkinsonism, dementia-parkinsonism or drug-induced parkinsonism. Other than drug-induced causes of secondary parkinsonism account for a small percentage of cases of parkinsonism and can be due to several causes. One of the possibilities is extrapontine myelinolysis (EPM). Myelinolysis results from rapid correction of hyponatremia and is generally located central in the pons, so-called central pontine myelinolysis (CPM) but can also be located outside the pons (EPM). Here, we describe a case of parkinsonism due to EPM without CPM with 4-year clinical and radiological [magnetic resonance imaging (MRI)] follow-up and we review the recent literature on this subject.</p>
    </sec>
    <sec id="Sec2">
      <title>Case report</title>
      <p>A 63-year-old woman was admitted to the hospital because of nausea, vomiting, difficulty speaking and impairment of coordination of her arms and legs. Laboratory studies showed a severe hyponatremia of 104&#xA0;mmol/l which resulted in an acute metabolic encephalopathy. This was corrected initially using hypertonic NaCl 1.5% and later using isotonic NaCl 0.9% infusions. After 18&#xA0;h the sodium concentration raised to 121&#xA0;mmol/l and 36&#xA0;h later it was 130&#xA0;mmol/l. During 1&#xA0;week of hospitalisation, she experienced an improvement and was discharged from the ward with a slight dysartria. In the past she had been diagnosed with breast carcinoma, diverticulosis and had undergone a cholecystectomy. Furthermore, she suffered from hypertension and was on drugs for this: B-blocking agent and diuretics (triamtereen-epitizide). The use of diuretics in combination with the vomiting was thought to have caused the severe hyponatremia and the drugs were discontinued.</p>
      <p>Eight days later she was readmitted to hospital with progressive dysartria, bradykinesia and loss of &#x201C;strength&#x201D; of her arms and legs. Within several days she deteriorated to a bed-ridden stage. Two weeks after this deterioration, without a clear diagnoses, she was referred to the neurology department in our hospital.</p>
      <p>During neurological examination the patient was alert and well-oriented. MMSE was 28/30, where she lost two points on memory and visuo-construction. She had a masked face and hypo-phonic speech. Examination of the cranial nerves showed no abnormalities, with normal eye movements. Her upper and lower limbs showed, left more than right-sided, rigidity with cogwheeling and bradykinesia. She had difficulty raising from a chair, and when walking her armswing was decreased. The postural reflexes were impaired. No tremor, dystonia or dyskinesias were noted. The remaining neurological examination was without abnormalities.</p>
      <p>Blood tests showed no abnormalities. Sodium was 142&#xA0;mmol/l, potassium 3.5&#xA0;mmol/l, ceruloplasmin and copper were normal, thyroid function and lactate in blood were normal, as was the chest X-ray. The T2-weighted images of the MRI of the brain showed bilateral and symmetric increased intensities in the nucleus caudatus and the putamen with sparing of the globus pallidus (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, top). There was no abnormal signal in the pons (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, top). T1-weighted images of both regions were normal.<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p><italic>Top</italic> T2-weighted magnetic resonance scan image showing bilateral symmetrical hyperintensities in caudate nucleus and putamen with sparing of the pons; there is also typical sparing of the pallidum. <italic>Bottom</italic> T2-weighted magnetic resonance scan after 4&#xA0;years of follow-up showing a normal intensities of caudate nucleus, putamen and pons</p></caption><graphic position="anchor" xlink:href="10072_2009_88_Fig1_HTML" id="MO1"/></fig></p>
      <p>Based on the clinical course, history of hyponatremia with correction and the abnormalities on the MRI-scan the diagnosis EPM without CPM was made. The patient recovered slowly and was discharged home with parkinsonism; dysartria, bradykinesia and rigidity. During follow-up at the outpatient clinic the patient gradually recovered from her parkinsonism. Three years and 9&#xA0;months after discharge neurological examination showed only a mild masked face, but further neurological examination was unremarkable. MRI at this stage showed no abnormalities on T2-weighted and FLAIR images in the nucleus caudatus and the putamen (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, bottom).</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>We describe a case of parkinsonism after correction of hyponatremia with radiological evidence of EPM without CPM with the longest follow-up reported in the literature.</p>
      <p>EPM without CPM causing parkinsonism has been reported in Pubmed seven times since 1990 (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR7">7</xref>]. In all reported cases, including our own case, a severe hyponatremia with fast correction was described, similar to our case. In seven of these cases an initial improvement of general symptoms due to the hyponatremia (e.g. confusion, epilepsy) was described after correction of the hyponatremia, with a secondary deterioration after which symptoms of parkinsonism developed. Spontaneous recovery of this second episode occurred in days to weeks. Six out of eight showed good recovery, which does not mean complete recovery, after a variable follow-up time.<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Cases described in literature from 1990 until now with parkinsonism due to EPM without CPM</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Article</th><th align="left">Cause of hyponatremia</th><th align="left">Hyponatremia</th><th align="left">Lucent interval between correction hyponatremia and start myelinolysis</th><th align="left">Follow-up</th><th align="left">Prognosis</th></tr></thead><tbody><tr><td align="left">Post (2009) (current case)</td><td align="left">Diuretics and vomiting</td><td align="left">Initial: 104&#xA0;mmol/l; correction to 121&#xA0;mmol/l in 18&#xA0;h and to 130&#xA0;mmol/l in 30&#xA0;h</td><td align="left">+</td><td align="left">4&#xA0;years</td><td align="left">Good recovery</td></tr><tr><td align="left">Sajith (2006)</td><td align="left">Addison&#x2019;s disease; exacerbated by dehydration and vomiting</td><td align="left">Initial: &lt;100&#xA0;mmol/l; correction to 130&#xA0;mmol/l over 5&#xA0;days</td><td align="left">+</td><td align="left">2&#xA0;months</td><td align="left">Good recovery</td></tr><tr><td align="left">Okada (2005)</td><td align="left">History transphenoidal resection and gamma knife treatment of prolactinoma; now episode of pneumonia and general sickness</td><td align="left">Initial: 109&#xA0;mmol/l; correction to 120&#xA0;mmol/l in 28&#xA0;h</td><td align="left">+</td><td align="left">3&#xA0;years</td><td align="left">Good recovery</td></tr><tr><td align="left">Koussa (2003)</td><td align="left">Diuretics</td><td align="left">Initial: 99&#xA0;meq/l; correction to 127&#xA0;meq/l&#xA0;&lt;&#xA0;24&#xA0;h</td><td align="left">+</td><td align="left">4&#xA0;months</td><td align="left">Good recovery</td></tr><tr><td align="left">Kim (2003)</td><td align="left"><italic>Cis</italic>-platinum and vomiting</td><td align="left">Initial: 98&#xA0;meq/l; correction to 128&#xA0;meq/l in 20&#xA0;h</td><td align="left">+</td><td align="left">4&#xA0;months</td><td align="left">Good recovery</td></tr><tr><td align="left">Salvesen [<xref ref-type="bibr" rid="CR5">5</xref>]</td><td align="left">Transphenoidal resection of pituarity adenoma. On hormonal substitution therapy; episode of water poisoning</td><td align="left">Initial: 110&#xA0;mmol/l; correction to 123&#xA0;mmol/l within the first 12&#xA0;h and to 139&#xA0;mmol/l after 28&#xA0;h</td><td align="left">+</td><td align="left">6&#xA0;months</td><td align="left">Good recovery</td></tr><tr><td align="left">Waragi (1998)</td><td align="left">Germinoma of the pineal gland and radiation with panhypopituitarism. On hormonal substitution therapy; adrenergic crisis following cold</td><td align="left">Initial: 105&#xA0;meq/l andere EH?; correction to 148&#xA0;meq/l in 7&#xA0;days</td><td align="left">+</td><td align="left">Not stated</td><td align="left">Not stated</td></tr><tr><td align="left">Tomita (1993)</td><td align="left">History of hypophysectomy after apoplexy with concurrent diabetes insipidus</td><td align="left">Initial: 103&#xA0;meq/l andere EH?;<break/>correction 126&#xA0;meq/l in 3&#xA0;days</td><td align="left">&#x2013;</td><td align="left">10&#xA0;months</td><td align="left">Progressive parkinsonism without reaction to dopaminergic therapy</td></tr></tbody></table></table-wrap></p>
      <p>EPM without CPM is described in 22% of cases with myelinolysis [<xref ref-type="bibr" rid="CR8">8</xref>]. These EPM lesions were most frequently seen in the cerebellum (55%), lateral geniculate body (41%), putamen (34%), thalamus (34%) and cerebral cortex/subcortex (34%) [<xref ref-type="bibr" rid="CR8">8</xref>]. CPM was first described in 1959 by Adams. [<xref ref-type="bibr" rid="CR9">9</xref>] In a series of 58 cases of myelinolysis with brain autopsy in 47% of patients myelinolysis was confined to the pons, while in 53% of patients lesions were also located outside of the pons; EPM. In 1976 Tomlinson suggested rapid correction of sodium as an etiological factor for myelinolysis [<xref ref-type="bibr" rid="CR9">9</xref>]. Myelinolysis, however, not only appears in adult or alcoholic patients with hyponatremia but can also occur with normal or elevated serum sodium levels [<xref ref-type="bibr" rid="CR10">10</xref>]. Nowadays it is believed that myelinolysis is caused by a dysbalance between brain electrolytes, especially sodium and chloride, and organic brain osmolites, e.g. creatine, taurine, glutamate. With the correction of serum hyponatremia a net shrinkage of the brain will occur. Oligodendroglial cells form a network around large neurons and appear to be vulnerable to physical stress related to shrinkage [<xref ref-type="bibr" rid="CR10">10</xref>] leading to myelinolysis in the typical predeliction sites for CPM and EPM. This dysbalance hypothesis has led to the recommendation that correction of hyponatremia should not excess 8&#xA0;mmol/l per day [<xref ref-type="bibr" rid="CR9">9</xref>].</p>
      <p>We conclude that EPM is a rare cause of parkinsonism that occurs after an initial period of recovery after rapid correction of hyponatremia. The prognosis based, also on the long term seems favourable, although the possibility of publication bias can lead to overestimation of this good prognosis.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Open Access</title>
      <p>This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sajith</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ditchfield</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Katifi</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title>Extrapontine myelinolysis presenting as acute parkinsonism</article-title>
          <source>BMC Neurol</source>
          <year>2006</year>
          <volume>6</volume>
          <fpage>33</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2377-6-33</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Sajith J, Ditchfield A, Katifi HA (2006) Extrapontine myelinolysis presenting as acute parkinsonism. BMC Neurol 6:33 <pub-id pub-id-type="pmid">16961933</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okada</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nomura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Furusyo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Otaguro</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nabeshima</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Amelioration of extrapontine myelinolysis and reversible parkinsonism in a patient with asymptomatic hypopituitarism</article-title>
          <source>Intern Med</source>
          <year>2005</year>
          <volume>44</volume>
          <issue>7</issue>
          <fpage>739</fpage>
          <lpage>742</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.44.739</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Okada K, Nomura M, Furusyo N, Otaguro S, Nabeshima S, Hayashi J (2005) Amelioration of extrapontine myelinolysis and reversible parkinsonism in a patient with asymptomatic hypopituitarism. Intern Med 44(7):739&#x2013;742 <pub-id pub-id-type="pmid">16093597</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koussa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nasnas</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Catatonia and Parkinsonism due to extrapontine myelinolysis following rapid correction of hyponatremia: a case report</article-title>
          <source>J Neurol</source>
          <year>2003</year>
          <volume>250</volume>
          <issue>1</issue>
          <fpage>103</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1007/s00415-003-0916-4</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Koussa S, Nasnas R (2003) Catatonia and Parkinsonism due to extrapontine myelinolysis following rapid correction of hyponatremia: a case report. J Neurol 250(1):103&#x2013;105 <pub-id pub-id-type="pmid">12528003</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>YA</given-names>
            </name>
          </person-group>
          <article-title>Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis</article-title>
          <source>Mov Disord</source>
          <year>2003</year>
          <volume>18</volume>
          <issue>3</issue>
          <fpage>342</fpage>
          <lpage>345</lpage>
          <pub-id pub-id-type="doi">10.1002/mds.10331</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kim JS, Lee KS, Han SR, Chung YA (2003) Decreased striatal dopamine transporter binding in a patient with extrapontine myelinolysis. Mov Disord 18(3):342&#x2013;345 <pub-id pub-id-type="pmid">12621642</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salvesen</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Extrapontine myelinolysis after surgical removal of a pituitary tumour</article-title>
          <source>Acta Neurol Scand</source>
          <year>1998</year>
          <volume>98</volume>
          <issue>3</issue>
          <fpage>213</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0404.1998.tb07297.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Salvesen R (1998) Extrapontine myelinolysis after surgical removal of a pituitary tumour. Acta Neurol Scand 98(3):213&#x2013;215 <pub-id pub-id-type="pmid">9786621</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waragai</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Satoh</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Serial MRI of extrapontine myelinolysis of the basal ganglia: a case report</article-title>
          <source>J Neurol Sci</source>
          <year>1998</year>
          <volume>161</volume>
          <issue>2</issue>
          <fpage>173</fpage>
          <lpage>175</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-510X(98)00275-5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Waragai M, Satoh T (1998) Serial MRI of extrapontine myelinolysis of the basal ganglia: a case report. J Neurol Sci 161(2):173&#x2013;175 <pub-id pub-id-type="pmid">9879700</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomita</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Satoh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Satoh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Seto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsujihata</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yoshimura</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Extrapontine myelinolysis presenting with parkinsonism as a sequel of rapid correction of hyponatraemia</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>1997</year>
          <volume>62</volume>
          <issue>4</issue>
          <fpage>422</fpage>
          <lpage>423</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp.62.4.422</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Tomita I, Satoh H, Satoh A, Seto M, Tsujihata M, Yoshimura T (1997) Extrapontine myelinolysis presenting with parkinsonism as a sequel of rapid correction of hyponatraemia. J Neurol Neurosurg Psychiatry 62(4):422&#x2013;423 <pub-id pub-id-type="pmid">9120471</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gocht</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Colmant</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
          <article-title>Central pontine and extrapontine myelinolysis: a report of 58 cases</article-title>
          <source>Clin Neuropathol</source>
          <year>1987</year>
          <volume>6</volume>
          <issue>6</issue>
          <fpage>262</fpage>
          <lpage>270</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gocht A, Colmant HJ (1987) Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 6(6):262&#x2013;270 <pub-id pub-id-type="pmid">3322623</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2004</year>
          <volume>75</volume>
          <issue>Suppl 3</issue>
          <fpage>iii22</fpage>
          <lpage>iii28</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp.2004.045906</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Martin RJ (2004) Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 75(Suppl 3):iii22&#x2013;iii28 <pub-id pub-id-type="pmid">15316041</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>WD</given-names>
            </name>
          </person-group>
          <article-title>Osmotic demyelination disorders: central pontine and extrapontine myelinolysis</article-title>
          <source>Curr Opin Neurol</source>
          <year>2000</year>
          <volume>13</volume>
          <issue>6</issue>
          <fpage>691</fpage>
          <lpage>697</lpage>
          <pub-id pub-id-type="doi">10.1097/00019052-200012000-00014</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Brown WD (2000) Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol 13(6):691&#x2013;697 <pub-id pub-id-type="pmid">11148672</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
